Google settles U.S. shareholder lawsuit over online drug ads
(Reuters) - Google Inc has agreed to create a $250 million internal program to disrupt rogue online pharmacies as part of a deal to end shareholder litigation over accusations the search company improperly allowed ads from non-U.S. drug sellers.
Context & Ripple Effects
This settlement closes the private-market sequel to Google's 2011 reckoning with the Justice Department, when the company forfeited $500 million generated by ads from Canadian online pharmacies under federal pressure. That forfeiture handed shareholders a ready-made theory: the ad revenue was tainted, so the board's oversight of it damaged the company.
The resolution announced August 8, 2014 is notable for its shape — no cash judgment against Google, but a confirmed $250 million internal program charged with disrupting rogue online pharmacies. The remedy lands on the ads operation itself, not the balance sheet.
First-order effects
- Google's shareholder litigation over non-U.S. drug-seller ads ends with the company committing $250 million to an internal anti-rogue-pharmacy program, a direct operating cost and compliance mandate for its ads business.
- The board and officers named in the suit escape a cash payout, trading litigation risk for a multi-year remediation obligation they will have to report against.
Second-order effects
- Pharmaceutical advertisers and affiliate networks feeding Google's auction face stricter vetting, since the program's funding depends on actually cutting off illegitimate sellers rather than merely screening them.
- The structure gives plaintiffs' lawyers a template: where a regulator has already extracted a forfeiture or settlement, a follow-on shareholder suit can convert that record into governance remedies without proving new facts.
Third-order effects
- If the pattern holds, major ad platforms internalize compliance programs as a standing cost of doing business, with enforcement arriving in two waves — regulators first, shareholders second — rather than one.
- Board-level oversight of ad-content risk becomes a litigable duty, pushing search companies to treat what their auctions sell as a governance issue, not just a policy one.
The trend: Shareholder suits piggybacking on government enforcement are becoming a standard second wave of accountability for how advertising platforms police what they sell.